Showing results (141-150 of 11,581) with videos related to

Sort By:
Pageof 1,159
The Journal of Chemical Physics|May 27, 2009
Vacuum-UV negative photoion spectroscopy of CF3Cl, CF3Br, and CF3IM J Simpson, R P Tuckett, K F Dunn, et al.
Chirality|July 12, 2002
A search for circular dichroism in the VUV photofragmentation mass spectra of 2-amino-1-butanolR A Mackie, R Browning, C J Latimer, et al.
Nucleic Acids Research|February 11, 1987
A monoclonal antibody to triplex DNA binds to eucaryotic chromosomesJ S Lee, G D Burkholder, L J Latimer, et al.
Pancreas|February 17, 2005
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expressionJohnathan C Maher, Niramol Savaraj, Waldemar Priebe, et al.
Digestion|January 1, 1987
Mucosal defences and gastroduodenal diseaseC Tasman-Jones, C Maher, L Thomsen, et al.
Diseases of the Nervous System|December 1, 1975
The effect of modified ECT on serum creatine phosphokinase. II. With subcutaneous atropineC L Rich, L A Cunningham, C C Maher, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 29, 2014
TBC1D1 reduces palmitate oxidation by inhibiting β-HAD activity in skeletal muscleA C Maher, J McFarlan, J Lally, et al.
Thrombosis and Haemostasis|February 12, 1999
Double fluorescent-amplification refractory mutation detection (dF-ARMS) of the factor V Leiden and prothrombin mutationsC Maher, D Crowley, C Cullen, et al.
Diseases of the Nervous System|December 1, 1975
The effect of modified ECT on serum creatine phophokinase, I. With intravenous atropineC L Rich, L A Cunningham, C C Maher, et al.
Molecular Cancer Therapeutics|February 20, 2007
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucoseJohnathan C Maher, Medhi Wangpaichitr, Niramol Savaraj, et al.
Pageof 1,159